Science European Regulators Reject Biogen and Eisai’s Alzheimer’s Treatment Biogen and Eisai today announced that the European Medicines Agency (EMA) has not recommended approval for their Alzheimer’s treatment, Leqembi.... By Liz F.July 24, 2024